Company / Revenue per Share
AXIM BIOTECHNOLOGIES, INC. Revenue per Share History
FY2011-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$0.00
FY2023
5-year range
$0.00 / $0.00
FY2019-FY2023
Trend
+219.5%
vs FY2022
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Revenue per Share changed +220% YoY in FY2023, a notable deviation from the 8-year average annual change of +72%.
Based on SEC 10-K filings.
0.00 in FY2023 with a 10-year CAGR of -21.4%.
Declined from $0.00 to $0.00 over the past 5 years.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -43.6%
- 10-Year CAGR
- -21.4%
Key checks
Key Insights
- In FY2023, revenue per share increased 219.5% year-over-year.
- Peak revenue per share was recorded in FY2018.
- Lowest revenue per share in the period was in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -18.18 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2023 | $0.00 | +219.5% |
| FY2022 | $0.00 | -98.2% |
| FY2018 | $0.00 | +295.7% |
| FY2017 | $0.00 | -23.7% |
| FY2016 | $0.00 | -20.3% |
| FY2015 | $0.00 | -34.5% |
| FY2013 | $0.00 | +73.1% |
| FY2012 | $0.00 | +162.6% |
| FY2011 | $0.00 | - |
As of FY2023 · SEC 10-K · Updated Jun 29, 2026